Home monitoring with connected mobile devices for asthma attack prediction with machine learning.
Journal
Scientific data
ISSN: 2052-4463
Titre abrégé: Sci Data
Pays: England
ID NLM: 101640192
Informations de publication
Date de publication:
08 06 2023
08 06 2023
Historique:
received:
24
10
2022
accepted:
15
05
2023
medline:
12
6
2023
pubmed:
9
6
2023
entrez:
8
6
2023
Statut:
epublish
Résumé
Monitoring asthma is essential for self-management. However, traditional monitoring methods require high levels of active engagement, and some patients may find this tedious. Passive monitoring with mobile-health devices, especially when combined with machine-learning, provides an avenue to reduce management burden. Data for developing machine-learning algorithms are scarce, and gathering new data is expensive. A few datasets, such as the Asthma Mobile Health Study, are publicly available, but they only consist of self-reported diaries and lack any objective and passively collected data. To fill this gap, we carried out a 2-phase, 7-month AAMOS-00 observational study to monitor asthma using three smart-monitoring devices (smart-peak-flow-meter/smart-inhaler/smartwatch), and daily symptom questionnaires. Combined with localised weather, pollen, and air-quality reports, we collected a rich longitudinal dataset to explore the feasibility of passive monitoring and asthma attack prediction. This valuable anonymised dataset for phase-2 of the study (device monitoring) has been made publicly available. Between June-2021 and June-2022, in the midst of UK's COVID-19 lockdowns, 22 participants across the UK provided 2,054 unique patient-days of data.
Identifiants
pubmed: 37291158
doi: 10.1038/s41597-023-02241-9
pii: 10.1038/s41597-023-02241-9
pmc: PMC10248342
doi:
Types de publication
Observational Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
370Subventions
Organisme : Asthma UK
ID : AUK-AC-2018-01
Organisme : Asthma UK
ID : AUK-AC-2018-01
Organisme : Asthma UK
ID : AUK-AC-2018-01
Organisme : Asthma UK
ID : AUK-AC-2018-01
Informations de copyright
© 2023. The Author(s).
Références
JAMIA Open. 2020 May 07;3(2):190-200
pubmed: 32734159
J Telemed Telecare. 2017 Feb;23(2):248-255
pubmed: 27036878
J Allergy Clin Immunol Pract. 2020 Jun;8(6):1972-1979.e8
pubmed: 32142961
Eur Respir J. 1999 Oct;14(4):902-7
pubmed: 10573240
BMC Med. 2017 Mar 17;15(1):64
pubmed: 28302126
BMJ Open. 2022 Oct 3;12(10):e064166
pubmed: 36192103
Respir Res. 2005 Oct 21;6:120
pubmed: 16242029
BMJ Open. 2017 Jan 24;7(1):e013935
pubmed: 28119390
Curr Allergy Asthma Rep. 2015 Jun;15(6):28
pubmed: 26141573
Prim Care Respir J. 2012 Sep;21(3):288-94
pubmed: 22751737
BMJ. 2009 Aug 11;339:b2803
pubmed: 19671932
Heart. 2018 Jul;104(13):1048-1049
pubmed: 29382691
Environ Health Perspect. 2017 Feb;125(2):254-261
pubmed: 27340894
Annu Int Conf IEEE Eng Med Biol Soc. 2020 Jul;2020:5673-5677
pubmed: 33019264
BMJ. 1989 Apr 22;298(6680):1068-70
pubmed: 2497892
Sci Data. 2018 May 22;5:180096
pubmed: 29786695
Lancet Reg Health Eur. 2022 Aug;19:100428
pubmed: 35756853
JMIR Mhealth Uhealth. 2016 Jun 10;4(2):e72
pubmed: 27287964
J Allergy Clin Immunol Pract. 2022 Feb;10(2):495-505.e2
pubmed: 34626858
Front Pediatr. 2019 Jun 25;7:256
pubmed: 31294006
Am J Respir Crit Care Med. 2009 Jul 1;180(1):59-99
pubmed: 19535666
J Asthma Allergy. 2022 Jun 29;15:855-873
pubmed: 35791395
BMC Pulm Med. 2019 Apr 8;19(1):74
pubmed: 30961573
BMJ. 2010 Jan 28;340:c181
pubmed: 20110312
Nat Biotechnol. 2017 Apr;35(4):354-362
pubmed: 28288104